B7-H1/PD-1 Blockade Therapy in Non–Small Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference13 articles.
1. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.;Sandler;N Engl J Med,2006
2. Targeting epidermal growth factor receptor in the management of lung cancer.;Mok;Semin Oncol,2014
3. Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor.;Berge;Semin Oncol,2014
4. Lung cancer immunotherapy.;Raez;Clin Med Res,2005
5. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.;Butts;Lancet Oncol,2014
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Chelator-to-Antibody Ratio on Development of 89Zr-iPET Tracer for Imaging of PD-L1 Expression on Tumor;International Journal of Molecular Sciences;2023-12-05
2. Risk factors influencing chemotherapy compliance and survival of elderly patients with non-small cell lung cancer;African Health Sciences;2023-10-11
3. Role of Surgical Pathologist for the Detection of Immuno-oncologic Predictive Factors in Non-small Cell Lung Cancers;Advances in Anatomic Pathology;2023-03-20
4. Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy;Frontiers in Oncology;2022-10-06
5. Prognostic significance of programmed death-1 and programmed death ligand-1 proteins in breast cancer;Human Antibodies;2022-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3